Clinical Trial Update: Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety, and tolerability of intravenous posaconazole followed by oral posaconazole suspension in patients at high ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• Posaconazole (Noxafil) (posaconazole)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection | Phase 1 | Status: COMPLETED | Results posted: 2013-11-15